Cargando…

Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features

BACKGROUND: The growth and metastasis of tumors depend on the development of an adequate blood supply via angiogenesis. Recent studies indicate that the inducible nitric oxide synthase (iNOS), vascular endothelial growth factor (VEGF) and the tumor suppressor p53 are fundamental play-markers of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Chang Wei, Wang, Li Dong, Jiao, Lian Hua, Liu, Bin, Zheng, Shu, Xie, Xin Ji
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2002
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC113262/
https://www.ncbi.nlm.nih.gov/pubmed/11978184
http://dx.doi.org/10.1186/1471-2407-2-8
_version_ 1782120234885316608
author Feng, Chang Wei
Wang, Li Dong
Jiao, Lian Hua
Liu, Bin
Zheng, Shu
Xie, Xin Ji
author_facet Feng, Chang Wei
Wang, Li Dong
Jiao, Lian Hua
Liu, Bin
Zheng, Shu
Xie, Xin Ji
author_sort Feng, Chang Wei
collection PubMed
description BACKGROUND: The growth and metastasis of tumors depend on the development of an adequate blood supply via angiogenesis. Recent studies indicate that the inducible nitric oxide synthase (iNOS), vascular endothelial growth factor (VEGF) and the tumor suppressor p53 are fundamental play-markers of the angiogenic process. Overexpression of iNOS and VEGF has been shown to induce angiogenesis in tumors. P53 suppresses angiogenesis by down-regulating VEGF and iNOS. The correlation of expression of p53, VEGF and iNOS and clinical features in gastric carcinogenesis, however, has not been well characterized. METHODS: The expression of p53, iNOS and VEGF in gastric precancerous and cancerous lesions and its relation with the clinical features was determined with immunohistochemistry (avidin-biotin-peroxidase complex method) on 55 randomly selected GC patients and 60 symptom-free subjects from the mass survey in the high-incidence area for GC in Henan, northern China. RESULTS: The positive immunostainig rates for p53, iNOS and VEGF in gastric carcinomas were 51%, 44% and 51%, respectively, and correlated well with TNM stages, but did not show significant difference among the groups with different degrees of gastric wall invasion depth by GC. A positive immunostaining reaction for the iNOS protein was significantly correlated with lymph node metastasis (p = 0.019; Spearman correlation coefficient). P53 protein accumulation was higher in the poorly-differentiated gastric carcinoma than in well-differentiated one. In gastric biopsies, no positive immunosatining was observed for p53, iNOS and VEGF in the histologically normal tissue and chronic superficial gastritis (CSG). However, p53, iNOS and VEGF positive immunostaining was observed in the tissues with different severities of lesions of chronic atrophic gastritis (CAG), intestinal metaplasia (IM) and dysplasia (DYS), and the positive rates increased with the lesion progression from CAG to IM to DYS. A high coincidental positive and negative immunostaining rate for p53, iNOS and VEGF was observed both in biopsy samples with CAG, IM and DYS from the symptom-free subjects and in gastric cancer tissue from the GC patients. CONCLUSIONS: The present results indicated that p53 protein accumulation and increased expression of iNOS and VEGF might be responsible for gastric carcinogenesis and tumor aggressiveness of gastric cancer.
format Text
id pubmed-113262
institution National Center for Biotechnology Information
language English
publishDate 2002
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-1132622002-05-23 Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features Feng, Chang Wei Wang, Li Dong Jiao, Lian Hua Liu, Bin Zheng, Shu Xie, Xin Ji BMC Cancer Research Article BACKGROUND: The growth and metastasis of tumors depend on the development of an adequate blood supply via angiogenesis. Recent studies indicate that the inducible nitric oxide synthase (iNOS), vascular endothelial growth factor (VEGF) and the tumor suppressor p53 are fundamental play-markers of the angiogenic process. Overexpression of iNOS and VEGF has been shown to induce angiogenesis in tumors. P53 suppresses angiogenesis by down-regulating VEGF and iNOS. The correlation of expression of p53, VEGF and iNOS and clinical features in gastric carcinogenesis, however, has not been well characterized. METHODS: The expression of p53, iNOS and VEGF in gastric precancerous and cancerous lesions and its relation with the clinical features was determined with immunohistochemistry (avidin-biotin-peroxidase complex method) on 55 randomly selected GC patients and 60 symptom-free subjects from the mass survey in the high-incidence area for GC in Henan, northern China. RESULTS: The positive immunostainig rates for p53, iNOS and VEGF in gastric carcinomas were 51%, 44% and 51%, respectively, and correlated well with TNM stages, but did not show significant difference among the groups with different degrees of gastric wall invasion depth by GC. A positive immunostaining reaction for the iNOS protein was significantly correlated with lymph node metastasis (p = 0.019; Spearman correlation coefficient). P53 protein accumulation was higher in the poorly-differentiated gastric carcinoma than in well-differentiated one. In gastric biopsies, no positive immunosatining was observed for p53, iNOS and VEGF in the histologically normal tissue and chronic superficial gastritis (CSG). However, p53, iNOS and VEGF positive immunostaining was observed in the tissues with different severities of lesions of chronic atrophic gastritis (CAG), intestinal metaplasia (IM) and dysplasia (DYS), and the positive rates increased with the lesion progression from CAG to IM to DYS. A high coincidental positive and negative immunostaining rate for p53, iNOS and VEGF was observed both in biopsy samples with CAG, IM and DYS from the symptom-free subjects and in gastric cancer tissue from the GC patients. CONCLUSIONS: The present results indicated that p53 protein accumulation and increased expression of iNOS and VEGF might be responsible for gastric carcinogenesis and tumor aggressiveness of gastric cancer. BioMed Central 2002-04-29 /pmc/articles/PMC113262/ /pubmed/11978184 http://dx.doi.org/10.1186/1471-2407-2-8 Text en Copyright © 2002 Feng et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.
spellingShingle Research Article
Feng, Chang Wei
Wang, Li Dong
Jiao, Lian Hua
Liu, Bin
Zheng, Shu
Xie, Xin Ji
Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features
title Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features
title_full Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features
title_fullStr Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features
title_full_unstemmed Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features
title_short Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features
title_sort expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC113262/
https://www.ncbi.nlm.nih.gov/pubmed/11978184
http://dx.doi.org/10.1186/1471-2407-2-8
work_keys_str_mv AT fengchangwei expressionofp53induciblenitricoxidesynthaseandvascularendothelialgrowthfactoringastricprecancerousandcancerouslesionscorrelationwithclinicalfeatures
AT wanglidong expressionofp53induciblenitricoxidesynthaseandvascularendothelialgrowthfactoringastricprecancerousandcancerouslesionscorrelationwithclinicalfeatures
AT jiaolianhua expressionofp53induciblenitricoxidesynthaseandvascularendothelialgrowthfactoringastricprecancerousandcancerouslesionscorrelationwithclinicalfeatures
AT liubin expressionofp53induciblenitricoxidesynthaseandvascularendothelialgrowthfactoringastricprecancerousandcancerouslesionscorrelationwithclinicalfeatures
AT zhengshu expressionofp53induciblenitricoxidesynthaseandvascularendothelialgrowthfactoringastricprecancerousandcancerouslesionscorrelationwithclinicalfeatures
AT xiexinji expressionofp53induciblenitricoxidesynthaseandvascularendothelialgrowthfactoringastricprecancerousandcancerouslesionscorrelationwithclinicalfeatures